XTL BIOPHARMACEUTICALS LTD. Proceeds From Exercise Of Warrants
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Proceeds From Exercise Of Warrants of $1.46 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromExerciseOfWarrants · last filed 2025-04-30
| Period end | Proceeds From Exercise Of Warrants 1 month | Proceeds From Exercise Of Warrants 6 month | Proceeds From Exercise Of Warrants 12 month |
|---|---|---|---|
| 2024-12-31 | $1.46M 20-F · filed 2025-04-30 | ||
| 2021-12-31 | $385.00K 20-F · filed 2023-03-22 | ||
| 2021-06-30 | $512.00K 6-K · filed 2021-08-24 | ||
| 2017-02-17 | $5.00M 6-K · filed 2022-08-24 |